Stay updated on Satralizumab in Thyroid Eye Disease Clinical Trial
Sign up to get notified when there's something new on the Satralizumab in Thyroid Eye Disease Clinical Trial page.

Latest updates to the Satralizumab in Thyroid Eye Disease Clinical Trial page
- Check4 days agoChange DetectedThe page footer now shows Revision: v3.6.4, replacing the previous Revision: v3.6.3. This indicates a minor site/software update.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe study's results status changed from 'No Results Posted' to 'Results Submitted', indicating that results have been submitted for the study and will be posted.SummaryDifference0.0%

- Check25 days agoChange DetectedThe page revision tag was updated to v3.6.3, indicating a new version of the page content. The previous revision tag v3.6.2 was removed.SummaryDifference0.0%

- Check32 days agoChange DetectedRevision: v3.6.2 is shown, replacing the prior v3.6.0. This reflects a minor update to the page build and does not alter the study content or its presentation.SummaryDifference0.0%

- Check46 days agoChange DetectedAdded new help/guide sections (How to Read a Study Record, Common Questions, How to Join a Study) and a recruitment notice stating no participants are being sought. The Intervention/Treatment label was standardized and the page revision updated to v3.6.0.SummaryDifference0.3%

- Check53 days agoChange DetectedThe page now displays a new revision number, v3.5.5, indicating a software release update; no study content appears to be modified.SummaryDifference0.0%

Stay in the know with updates to Satralizumab in Thyroid Eye Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Satralizumab in Thyroid Eye Disease Clinical Trial page.